BioMarin Pharmaceutical
BioMarin Pharmaceutical
- Performance
- Contributions
Year
Metric
Topic
Research Policy
Importance
Metric type
| Metrics | Value | |
|---|---|---|
 Modern Slavery Statement
Research | community assessed
|
Yes
|
|
|
MSA Statement Approval
Research | community assessed
|
Approved by Board
|
|
|
MSA statement homepage link
Research | community assessed
|
Yes
Yes, No
2018
|
|
|
MSA statement signed
Research | community assessed
|
Signed by Director
|
|
 MSA Business Performance Indicators
Research | community assessed
|
No
Yes, In Development, No
2017
|
|
|
MSA Identification of risks
Research | community assessed
|
No
|
|
|
MSA incidents identified
Research | community assessed
|
No
Yes, No
2017
|
|
|
MSA incidents remediation (revised)
Research | community assessed
|
No
|
|
|
MSA Performance Indicators
Research | community assessed
|
No
Yes, In Development, No
2017
|
|
|
MSA policy (revised)
Research | community assessed
|
Suppliers comply with laws and company’s policies (direct / tier 1),
Prohibit use of forced labour (direct / tier 1), Code of conduct or supplier code includes clauses on slavery and human trafficking (direct / tier 1), Prohibit use of child labour (direct / tier 1) |
|
|
MSA risk assessment
Research | community assessed
|
Conducting research
|
|
|
MSA risk management (revised)
Research | community assessed
|
Audits of suppliers (self- reporting),
In Development |
|
|
MSA supply chain disclosure
Research | community assessed
|
Geographical
Geographical, Facility/Supplier, No
2017
|
|
|
MSA training (revised)
Research | community assessed
|
Procurement / purchasing
|
|
|
MSA whistleblowing mechanism (revised)
Research | community assessed
|
Hotline (direct employees)
|